Neutrophil Gelatinase Associated Lipocalin Detection Kit (Fluorescence Dry Quantitative Immunoassay) Download the picture album

【 Characteristics 】

Method: fluorescence dry quantitative immunoassay Assay measuring range: 50ng/mL ~ 5000ng/mL Incubation time: 15min Sample: Human serum ,plasma (EDTA anticoagulant), whole blood (EDTA anticoagulant),Urine Reference range:  Urine<100ng/mL  Human serum, plasma, whole blood<180ng/mL Storage and Stability:  Detection Buffer is stable at 2°C ~8°C for 15 months.  Sealed Test Device is stable at 2°C~30°C for 15 months.

Clinical application

Clinical Application

l  Routine monitoring of critically ill patients

AKI has a prevalence of more than 50% in the ICU and a mortality rate of 50-80% in patients who are to be dialyzed. NGAL is capable of early diagnosis of AKI complications in critically ill patients.

l  Early diagnosis of AKI after organ transplantation

Routine testing after kidney transplantation allows early assessment of the need for dialysis and functional recovery of the transplanted kidney within 1 week after surgery.

l  Postoperative monitoring of coronary artery bypass grafting (CABG)

Earlier diagnosis of acute kidney injury in patients undergoing CABG can be achieved by measuring postoperative plasma NGAL concentration at 2 h.

l  Early diagnosis of contrast-induced nephropathy (CIN)

²  Urinary NGAL of CIN patients showed significant changes 24h after angiography, while levels of other markers such as serum creatinine (SCr) concentration do not change significantly at this time.

²  NGAL rises rapidly in response to kidney injury, preceding changes in creatinine by as much as 2 to 3 days.

l  Prediction of the risk of progression of chronic kidney disease (CKD)

The risk of CKD progression can increase by 3% and 2% for each 10 ng/mL increase in serum NGAL and urine NGAL concentrations, respectively.


Quality System